1. Home
  2. MC vs SWTX Comparison

MC vs SWTX Comparison

Compare MC & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MC
  • SWTX
  • Stock Information
  • Founded
  • MC 2007
  • SWTX 2017
  • Country
  • MC United States
  • SWTX United States
  • Employees
  • MC N/A
  • SWTX N/A
  • Industry
  • MC Investment Managers
  • SWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MC Finance
  • SWTX Health Care
  • Exchange
  • MC Nasdaq
  • SWTX Nasdaq
  • Market Cap
  • MC 3.6B
  • SWTX 3.0B
  • IPO Year
  • MC 2014
  • SWTX 2019
  • Fundamental
  • Price
  • MC $51.63
  • SWTX $37.92
  • Analyst Decision
  • MC Hold
  • SWTX Strong Buy
  • Analyst Count
  • MC 7
  • SWTX 5
  • Target Price
  • MC $62.50
  • SWTX $72.40
  • AVG Volume (30 Days)
  • MC 1.3M
  • SWTX 2.2M
  • Earning Date
  • MC 04-23-2025
  • SWTX 05-01-2025
  • Dividend Yield
  • MC 5.03%
  • SWTX N/A
  • EPS Growth
  • MC N/A
  • SWTX N/A
  • EPS
  • MC 1.93
  • SWTX N/A
  • Revenue
  • MC $1,194,545,000.00
  • SWTX $191,589,000.00
  • Revenue This Year
  • MC $22.14
  • SWTX $85.98
  • Revenue Next Year
  • MC $16.52
  • SWTX $69.16
  • P/E Ratio
  • MC $26.80
  • SWTX N/A
  • Revenue Growth
  • MC 39.75
  • SWTX 3417.33
  • 52 Week Low
  • MC $46.24
  • SWTX $28.21
  • 52 Week High
  • MC $82.89
  • SWTX $62.00
  • Technical
  • Relative Strength Index (RSI)
  • MC 38.27
  • SWTX 39.33
  • Support Level
  • MC $50.27
  • SWTX $36.08
  • Resistance Level
  • MC $53.32
  • SWTX $38.77
  • Average True Range (ATR)
  • MC 3.38
  • SWTX 3.21
  • MACD
  • MC 0.17
  • SWTX -0.17
  • Stochastic Oscillator
  • MC 34.01
  • SWTX 36.05

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

Share on Social Networks: